Overview of Antibodies Against Oxidized LDL Over Three Decades
Author Information
Author(s): Wonisch Willibald, Tatzber Franz, Lindschinger Meinrad, Falk Andreas, Resch Ulrike, Mörkl Sabrina, Zarkovic Neven, Cvirn Gerhard
Primary Institution: Medical University of Graz
Conclusion
The study reviews the clinical relevance of antibodies against oxidized low-density lipoprotein (oLAb) and their implications in various diseases over the past three decades.
Supporting Evidence
- Antibodies against oxidized LDL are important for the immune system to maintain homeostasis.
- Oxidative stress is linked to various diseases, including cardiovascular diseases and diabetes.
- Research has shown that dietary factors can influence oLAb levels in different populations.
Takeaway
This study looks at how antibodies that fight against bad cholesterol can help us understand and treat diseases like heart problems and diabetes.
Methodology
The review summarizes findings from various studies using enzyme-linked immunosorbent assay (ELISA) to measure oLAb levels.
Limitations
The review is limited to studies using a specific commercial standardized method and does not include custom-made assays.
Participant Demographics
The studies included participants aged 21 to 74 years, with a sample that was 52.4% female.
Statistical Information
P-Value
p<0.01
Confidence Interval
95% CI 74.4–1681
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website